For a patient with spontaneous bacterial peritonitis caused by methicillin‑sensitive Staphylococcus aureus and impaired renal function (creatinine 2.1 mg/dL), which antibiotic is the most appropriate first‑line therapy, and what are the preferred alternatives if there is a penicillin allergy?

Recommended Antibiotic for MSSA Spontaneous Bacterial Peritonitis with Renal Impairment

For this patient with MSSA spontaneous bacterial peritonitis and creatinine 2.1 mg/dL, cefazolin is the optimal first-line antibiotic, prioritized over cloxacillin due to significantly lower nephrotoxicity risk in the setting of existing renal dysfunction.

Primary Recommendation: Cefazolin

The 2021 AASLD guidelines recommend IV third-generation cephalosporin as first-line empirical therapy for community-acquired SBP 1. However, your culture has identified MSSA, allowing targeted therapy. While the guideline focuses on empirical coverage, recent high-quality evidence specifically addresses MSSA treatment in renal impairment.

Why Cefazolin Over Cloxacillin in This Case:

• Renal protection is critical: A 2025 study demonstrated that cloxacillin causes AKI in 42.6% of patients with prior glycopeptide exposure versus 21.0% without, and identified cloxacillin as an independent predictor of AKI (aOR 3.45) 2. Another 2025 kidney-sparing protocol study showed systematic cefazolin use in patients with creatinine clearance <60 mL/min reduced AKI from 56% to 37% (p=0.045) and dialysis requirements from 8% to 1% (p=0.017), with equivalent efficacy 3.

• Your patient has creatinine 2.1 mg/dL: This represents at least Stage 2 AKI per AASLD criteria 1, placing them at extremely high risk for progression to hepatorenal syndrome—which carries 90% mortality 4.

• Efficacy is equivalent: Both cefazolin and antistaphylococcal penicillins are first-line for MSSA 5, with cefazolin demonstrating non-inferior outcomes in multiple studies 3.

Dosing Strategy

Cefazolin 2g IV every 8 hours, adjusted for renal function:

• With creatinine 2.1 mg/dL (estimated CrCl ~30-50 mL/min), reduce to 1-2g every 12 hours
• Duration: 5-7 days 1

Critical Adjunctive Therapy

IV albumin is mandatory 1:

• 1.5 g/kg on Day 1
• 1.0 g/kg on Day 3
• Maximum 100g per day 6

Your patient has both renal dysfunction (creatinine 2.1) and likely jaundice (viral hepatitis background)—the exact population shown to benefit most from albumin in preventing progression to hepatorenal syndrome 1.

Monitoring Requirements

1. Repeat diagnostic paracentesis at 48 hours 1:

   • Assess PMN count decrease
   • <25% reduction from baseline = treatment failure
   • Requires broadening coverage and imaging to exclude secondary peritonitis

2. Withdraw diuretics immediately 1, 6

3. Monitor creatinine every 2-4 days during hospitalization 6

Alternative if Penicillin Allergy

If true penicillin allergy exists:

• Vancomycin is the alternative, BUT this is problematic given existing renal impairment
• A 2015 decision analysis showed vancomycin resulted in lowest cure rates (67.3% vs 83-84% for cefazolin strategies) and highest adverse drug reactions (5.2%) 7
• Cefazolin can still be used if allergy history excludes anaphylactic features (no urticaria, angioedema, bronchospasm, anaphylaxis) 7, 8
• Consider allergy evaluation with skin testing to enable cefazolin use 7

Priority Ranking from Your Susceptibility Panel

Based on your culture showing susceptibility to multiple agents, the priority order is:

1. Cefazolin (not listed but first-generation cephalosporin, equivalent to listed agents)
2. Cloxacillin (from your list) - ONLY if renal function normal
3. Vancomycin (from your list) - reserve for true penicillin allergy
4. Ciprofloxacin/Cotrimoxazole - NOT appropriate for serious MSSA infections like SBP 8
5. Gentamicin - AVOID in renal impairment
6. Linezolid - reserve for resistant organisms 8

Critical Pitfalls to Avoid

• Do not use cloxacillin in this patient with creatinine 2.1—the nephrotoxicity risk outweighs any theoretical benefit
• Do not skip albumin—this is as important as antibiotics for preventing mortality 1
• Do not continue diuretics—immediate withdrawal is essential 1, 6
• Do not assume vancomycin is "safer" for kidneys—it has worse outcomes and significant nephrotoxicity 7

The combination of cefazolin plus IV albumin, with diuretic withdrawal and close monitoring, provides optimal efficacy while minimizing the catastrophic risk of hepatorenal syndrome progression in this vulnerable patient.